May 30 (Reuters) - The U.S. government is nearing an agreement to fund a late-stage trial of Moderna's (MRNA.O), opens new tab mRNA bird flu vaccine, the Financial Times reported on Thursday ...

Moderna Inc. is in discussions with large drugmakers and financial firms to get funding for some late-stage vaccine trials as ...

The U.S. government is nearing an agreement to fund a late-stage trial of Moderna’s mRNA pandemic bird flu vaccine, the Financial Times reported on Thursday, as an H5N1 outbreak spreads through ...

Moderna announced on Tuesday a deal with the US government to fund a late-stage trial of its pandemic bird flu vaccine. The announcement comes after months of speculation surrounding the Cambridge ...

WATCH: Should we keep drinking it? Health and medical editor Anna Kuchment has what consumers need to know. Moderna is nearing a deal with the US government to fund a late-stage trial of its bird ...

The U.S. government is reportedly close to finalizing a deal with Moderna to fund its bird flu mRNA vaccine trial as concerns remain surrounding the outbreak in poultry and cattle. The Financial ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. The US government is nearing an agreement to bankroll a late-stage trial of Moderna’s mRNA pandemic bird ...

Moderna shares climbed 2.4% premarket on Thursday after a report that the U.S. government is near a deal to fund a late-stage trial of the drugmaker’s experimental mRNA bird-flu vaccine.